Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
04/2010
04/29/2010US20100105866 Microfluidic manipulation of fluids and reactions
04/29/2010US20100105863 Method For Producing Acylated Peptides
04/29/2010US20100105617 C-Terminal Attachment of Two Chemical Groups to Peptides
04/29/2010US20100105089 Quantum dot biotags
04/29/2010US20100104608 Reactive surgical implant
04/29/2010US20100101954 Compositions, Methods, Devices, and Systems for Nucleic Acid Fractionation
04/29/2010CA2742043A1 Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
04/28/2010EP2180054A1 Methods and compositions for prolonging elimination half-times of bioactive compounds
04/28/2010EP2178901A2 Method for purifying or detecting a target protein
04/28/2010EP2178834A1 Three-functional pseudo-peptidic reagent, and uses and applications thereof
04/28/2010EP1487854B1 Novel isoform of vascular endothelial cell growth inhibitor (vegi)
04/28/2010CN1688600B Template-fixed peptidomimetics with antibacterial activity
04/28/2010CN101698681A Chimeric polypeptide with dual-targeting function and applications thereof
04/28/2010CN101698680A PEG-gelchromatography combined purification method for egg yolk immunoglobulins (IgY)
04/27/2010USRE41286 cartilage regeneration and repair product that induces cell ingrowth into a bioresorbable material and cell differentiation into cartilage tissue; comprises at least one TGF beta protein and at least one bone morphogenetic protein
04/27/2010US7705122 mTOR ligands and polynucleotides encoding mTOR ligands
04/27/2010US7705120 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
04/27/2010US7705118 Methods for preparing internally constrained peptides and peptidomimetics
04/27/2010US7704924 Library of compounds comprising pyrrolobenzodiazepine moieties
04/27/2010US7704708 Modified mutein having mutation which causes altered steric hindrance, charge repulsion and/or improvement of solubility by changing interfacial hydrophobic residues to less hydrophobic or hydrophilic residues; for use in capture and purification of biomolecules
04/27/2010US7704496 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
04/27/2010CA2532581C Pre-cast electrophoresis slab gels from supplemented monomer solutions
04/27/2010CA2323776C Cytokine receptor common gamma chain like
04/27/2010CA2245379C Superpotent calcitonin analogs having greatly increased hypocalcemic action in vivo
04/27/2010CA2162353C Interferon-.gamma. production inducing polypeptide, monoclonal antibody, and agent for interferon-.gamma. susceptive disease
04/22/2010WO2010045648A2 Methods for removing nicotine and other alkaloids from soluble leaf proteins in solanaceous and other plant species
04/22/2010WO2010043703A1 Removal of host cell proteins
04/22/2010WO2010043701A1 Clarification process
04/22/2010WO2010043700A1 Clarification process at higher cell density
04/22/2010WO2010043230A1 Multiligand constructs
04/22/2010WO2008047241A3 Modified corticotropin releasing factor peptides and uses thereof
04/22/2010US20100099855 Recombinant protein comprising starch binding domain and use thereof
04/22/2010US20100099831 Solid phase immobilized trifunctional linker
04/22/2010US20100099607 Casein complexes
04/22/2010US20100099575 Novel polypeptide scaffolds and use thereof
04/22/2010US20100099185 Method of making biologically active alpha-beta peptides
04/22/2010US20100099142 Processing of Peptides and Proteins
04/22/2010US20100099113 Minimized small peptides with high affinity for factor viii and factor viii-like proteins
04/22/2010US20100098729 Novel surface exposed immunoglobulin d-binding protein from foraxella catarrhalis
04/22/2010US20100096251 Methods and Processes for Attaching Compounds to Matrices
04/22/2010US20100095749 Protein crystallizing agent and method of crystallizing protein therewith
04/22/2010CA2778066A1 Methods for removing nicotine and other alkaloids from soluble leaf proteins in solanaceous and other plant species
04/22/2010CA2740554A1 Multiligand constructs
04/22/2010CA2739501A1 Clarification process at higher cell density
04/22/2010CA2739392A1 Clarification process
04/21/2010EP2177902A1 Method and system for multi-stage isoelectric focussing
04/21/2010EP2177620A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
04/21/2010EP2177528A1 Process for the preparation of mixtures of trifluoroacetyl glatiramer acetate using purified hydrobromic acid
04/21/2010EP2176292A1 Antibody purification process by precipitation
04/21/2010CN1978462B Imidazoline modified amino acid, and its synthesizing method and use for polypeptide marking
04/21/2010CN1891836B Method for quantitative measurement of gene expression based on paraffin-embedded tissue specimens
04/21/2010CN1763084B High purity cyclosporin A preparation method
04/21/2010CN101696241A Method for inducing and extracting metallothionein from housefly larva
04/21/2010CN101696238A Plant total protein extracting solution and application thereof
04/21/2010CN101696236A Method for synthesizing atosiban by solid phase
04/21/2010CN101696235A Daptomycin analog and full solid phase synthesis preparation method thereof
04/21/2010CN101696230A Two-dimensional electrophoresis method for protein
04/21/2010CA2641448A1 Synthetic antigen mimetics matrices immuno-reactive with rheumatoid arthritis auto-antibodies
04/20/2010US7700745 Method for separating carbohydrate in glycoside-linkage-having compound, carbohydrate separating system, carbohydrate separating reagent kit, standard sample for carbohydrate separation, and evaluation system
04/20/2010US7700744 Method for isolating proteins or protein and nucleic acid associations, or particle and protein complexes, reagent and uses
04/20/2010US7700743 A chromatography media such as silica controlled pore glass or agarose containing an affinity ligand such as 2-Aminobenzimidazole (ABI) or aminomethylbenzimidazole (AMBI); great degree of selectivity, particularly towards proteins such as IgG
04/20/2010US7700736 PRO350 antibodies
04/20/2010US7700730 Using viral capsid protein comprising RGD domain (arginine-glycine-aspartic acid) to treat and prevent cell proliferative, nervous system, autoimmune and allergic disorders
04/20/2010US7700724 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders
04/20/2010US7700723 having L-sorbosone dehydrogenase activity
04/20/2010US7700571 Compositions and methods for liver growth and liver protection
04/20/2010US7700553 Selective inhibition of NF-κB activation by peptides designed to disrupt nemo oligomerization
04/20/2010US7700550 Telavancin or its hydrochloride salt for infection, including MRSA infections; reduced tissue accumulation and/or nephrotoxicity
04/20/2010US7700523 zinc finger motifs are randomised in overlapping regions and to smart libraries incorporating limited directed randomisation at selected position
04/20/2010US7700318 polypeptide comprising a TNF neutralizer domain, an IL-1 receptor antagonist domain, and a dimerization domain; rheumatoid arthritis or psoriasis
04/20/2010US7700306 characterising a polypeptide by matrix assisted laser desorption ionization (MALDI) mass spectrometry; improving sensitivity, and can increase the number of peptides that are detected from a protein
04/20/2010US7700276 pulsing blood cells present in the whole blood sample of step with an identical/similar and/or different immunomodulatory agent as present in the subject using a device or kit; diagnosis/prognosis/monitoring of a clinical status affecting the immune system
04/20/2010US7700087 Compounds and methods to inhibit or augment an inflammatory response
04/20/2010CA2377468C Peptide acceptor ligation methods
04/15/2010WO2010042654A2 Recombinant nell protein production
04/15/2010WO2010042247A1 Microfluidic devices and methods of using the same
04/15/2010WO2010041742A1 Method for introducing dota
04/15/2010WO2010041425A1 Method for producing a peptide
04/15/2010WO2010040988A1 Purification process for fragment antibodies
04/15/2010WO2010040660A1 Pseudoproline dipeptides
04/15/2010WO2010040214A1 Digital microfluidic method for protein extraction by precipitation from heterogeneous mixtures
04/15/2010WO2010015287A3 Template-fixed peptidomimetics
04/15/2010WO2010008159A3 Mass- and property-tuned variable mass labeling reagents and analytical methods for simultaneous peptide sequencing and multiplexed protein quantification using thereof
04/15/2010US20100093982 Device and method for precipitation of peptides
04/15/2010US20100093977 Altered Antibodies
04/15/2010US20100093934 Pegylation of recombinant blood coagulation factors in the presence of bound antibodies
04/15/2010US20100093102 Mesoporous metal oxide materials for phosphoproteomics
04/15/2010US20100093086 Stapled Peptides and Method of Synthesis
04/15/2010US20100093059 Method for the Preparation of Sulfated Cellulose Membranes and Sulfated Cellulose Membranes
04/15/2010US20100093054 Novel methods for recovery of leaf proteins
04/15/2010US20100093001 Means and methods for the production of amyloid oligomers
04/15/2010US20100089754 Method of measuring microparticles having nucleic acid and apparatus therefor
04/15/2010US20100089753 Fluorescent detection of proteins in polyacrylamide gels
04/15/2010DE102004044419B4 Verfahren zur Aufreinigung eines von Willebrand Faktors mittels Hydroxylapatit-Durchlaufchromatographie Process for the purification of von Willebrand factor by hydroxyapatite-flow chromatography
04/15/2010CA2740106A1 Digital microfluidic method for protein extraction by precipitation from heterogeneous mixtures
04/15/2010CA2740079A1 Methods of making concentrated fibrinogen- and platelet-containing compositions
04/15/2010CA2739608A1 Recombinant nell protein production
04/15/2010CA2737675A1 Pseudoproline dipeptides
04/14/2010EP2175019A2 Quasirandom structure and function guided synthesis methods
04/14/2010EP2174946A1 Methods for chemically synthesizing immunoglobulin chimeric proteins